These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19822850)

  • 21. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.
    Krzystolik MG; Afshari MA; Adamis AP; Gaudreault J; Gragoudas ES; Michaud NA; Li W; Connolly E; O'Neill CA; Miller JW
    Arch Ophthalmol; 2002 Mar; 120(3):338-46. PubMed ID: 11879138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates.
    Nork TM; Dubielzig RR; Christian BJ; Miller PE; Miller JM; Cao J; Zimmer EP; Wiegand SJ
    Arch Ophthalmol; 2011 Aug; 129(8):1042-52. PubMed ID: 21825187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L; Chen H; Tuo J; Gao X; Chen L
    Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
    Chan WM; Lai TY; Liu DT; Lam DS
    Am J Ophthalmol; 2007 Jun; 143(6):977-983. PubMed ID: 17459318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
    Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM; Lai TY; Liu DT; Lam DS
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal infliximab and choroidal neovascularization in an animal model.
    Olson JL; Courtney RJ; Mandava N
    Arch Ophthalmol; 2007 Sep; 125(9):1221-4. PubMed ID: 17846362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of inhibitory effects of an antiangiogenic somatostatin-camptothecin conjugate on laser-induced choroidal neovascularization in rats.
    Bezerra Y; Fuselier JA; Peyman GA; Oner H; Drouant G; Coy DH
    Retina; 2005; 25(3):345-54. PubMed ID: 15805913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis.
    Fine HF; Zhitomirsky I; Freund KB; Barile GR; Shirkey BL; Samson CM; Yannuzzi LA
    Retina; 2009 Jan; 29(1):8-12. PubMed ID: 18784620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761.
    Fu Y; Ponce ML; Thill M; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5184-90. PubMed ID: 17962472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
    Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
    Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis.
    Sui A; Zhong Y; Demetriades AM; Shen J; Su T; Yao Y; Gao Y; Zhu Y; Shen X; Xie B
    Med Sci Monit; 2018 Aug; 24():5860-5873. PubMed ID: 30133427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic effects of bisphosphonates on laser-induced choroidal neovascularization in mice.
    Nagai T; Imai H; Honda S; Negi A
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5716-21. PubMed ID: 18055824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.
    Rosenfeld PJ; Schwartz SD; Blumenkranz MS; Miller JW; Haller JA; Reimann JD; Greene WL; Shams N
    Ophthalmology; 2005 Jun; 112(6):1048-53. PubMed ID: 15885778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization.
    Zhu Q; Ziemssen F; Henke-Fahle S; Tatar O; Szurman P; Aisenbrey S; Schneiderhan-Marra N; Xu X; ; Grisanti S
    Ophthalmology; 2008 Oct; 115(10):1750-5, 1755.e1. PubMed ID: 18708261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
    Kinose F; Roscilli G; Lamartina S; Anderson KD; Bonelli F; Spence SG; Ciliberto G; Vogt TF; Holder DJ; Toniatti C; Thut CJ
    Mol Vis; 2005 May; 11():366-73. PubMed ID: 15951738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study.
    Costa RA; Jorge R; Calucci D; Cardillo JA; Melo LA; Scott IU
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4569-78. PubMed ID: 17003454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a novel octapeptide urokinase fragment, A6, on experimental choroidal neovascularization in the monkey.
    Koh HJ; Freeman WR; Azen SP; Flaxel CJ; Labree LD; Cheng L; Wills M; Jones TR
    Retina; 2006 Feb; 26(2):202-9. PubMed ID: 16467679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.